相似文献
1
Inhibition of tolbutamide metabolism by substituted imidazole drugs in vivo: evidence for a structure-activity relationship.
Br J Pharmacol. 1985 May;85(1):121-6. doi: 10.1111/j.1476-5381.1985.tb08838.x.
2
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.
Br J Clin Pharmacol. 1988 Jul;26(1):23-9. doi: 10.1111/j.1365-2125.1988.tb03359.x.
3
Lack of efficacy of cimetidine and ranitidine as inhibitors of tolbutamide metabolism.
Eur J Clin Pharmacol. 1988;34(6):653-6. doi: 10.1007/BF00615234.
4
Inhibition of metabolism of the 'nonclassical' antifolate, trimetrexate (2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline) by drugs containing an imidazole moiety.
Pharmacology. 1985;30(5):266-72. doi: 10.1159/000138077.
5
Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.
Br J Pharmacol. 1984 Mar;81(3):557-62. doi: 10.1111/j.1476-5381.1984.tb10109.x.
6
Induction and inhibition of rat hepatic drug metabolism by N-substituted imidazole drugs.
Drug Metab Dispos. 1987 May-Jun;15(3):335-43.
7
Sulfamethizole-induced inhibition of diphenlhydantoin, tolbutamide, and warfarin metabolism.
Clin Pharmacol Ther. 1975 Jun;17(6):731-4. doi: 10.1002/cpt1975176731.
8
Inhibition of microsomal phenytoin metabolism by nafimidone and related imidazoles. Potency and structural considerations.
Drug Metab Dispos. 1985 Jul-Aug;13(4):430-7.
9
Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):219-27. doi: 10.1007/BF00614021.
10
[Metabolism in vitro and metabolic clearance in vivo of tolbutamide in rats with experimental cholestasis].
Verh Dtsch Ges Inn Med. 1976;82 Pt 1:297-300.
引用本文的文献
1
Clonidine effects on disposition of xenobiotics in rats: inhibited elimination of flow-limited but not extraction-limited agents.
Br J Pharmacol. 1988 May;94(1):97-102. doi: 10.1111/j.1476-5381.1988.tb11503.x.
2
In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines.
Br J Clin Pharmacol. 1988 Jul;26(1):23-9. doi: 10.1111/j.1365-2125.1988.tb03359.x.
3
Proceedings of the British Pharmacological Society, Clinical Pharmacology Section. 5-7 April 1989, Bristol. Abstracts.
Br J Clin Pharmacol. 1989 Aug;28(2):211P-247P. doi: 10.1111/j.1365-2125.1989.tb05422.x.
4
Comparative effects of two antimycotic agents, ketoconazole and terbinafine on the metabolism of tolbutamide, ethinyloestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro.
Br J Clin Pharmacol. 1989 Aug;28(2):166-70. doi: 10.1111/j.1365-2125.1989.tb05410.x.
5
Evaluation of hepatic dysfunction in endotoxin pretreated rats using tolbutamide as a marker.
Eur J Drug Metab Pharmacokinet. 1990 Jul-Sep;15(3):203-9. doi: 10.1007/BF03190205.
本文引用的文献
1
The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat.
Biochem Pharmacol. 1980 Nov 15;29(22):3075-80. doi: 10.1016/0006-2952(80)90448-7.
2
Cimetidine potentiates the anticoagulant effect of warfarin by inhibition of drug metabolism.
Biochem Pharmacol. 1980 Jul 1;29(13):1971-2. doi: 10.1016/0006-2952(80)90114-8.
3
Inhibitors of hepatic mixed function oxidases--V. Inhibition of aminopyrine N-demethylation and enhancement of aniline hydroxylation by benzoxazole derivatives.
Biochem Pharmacol. 1982 May 1;31(9):1795-8. doi: 10.1016/0006-2952(82)90690-6.
4
Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat.
Br J Pharmacol. 1984 Mar;81(3):557-62. doi: 10.1111/j.1476-5381.1984.tb10109.x.
5
Dazoxiben: a pharmacological tool or clinical candidate?
Br J Clin Pharmacol. 1983;15 Suppl 1(Suppl 1):13S-16S. doi: 10.1111/j.1365-2125.1983.tb02101.x.
6
Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole.
Arch Int Pharmacodyn Ther. 1981 May;251(1):26-38.
7
8
Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity.
Drug Metab Dispos. 1980 Jul-Aug;8(4):191-6.
9
The effects of 1-alkylimidazoles on hepatic drug-metabolizing enzyme activity.
Xenobiotica. 1974 Apr;4(4):209-17. doi: 10.3109/00498257409062539.
10
Imidazole derivatives--a new class of microsomal enzyme inhibitors.
Biochem Pharmacol. 1972 Dec 1;21(23):3187-92. doi: 10.1016/0006-2952(72)90147-5.
Zotero 插件